British-Swedish Company AstraZeneca and the Covishield Vaccine
AstraZeneca, in collaboration with Oxford, developed the Covid vaccine known as Covishield.
Legal Action Against AstraZeneca
The parents of a young woman who passed away after receiving the Covishield vaccine are planning to sue AstraZeneca.
AstraZeneca recently admitted that its vaccine can lead to rare side effects like blood clots and low platelet count.
Potential Lawsuit Details
Venugopalan Govindan, who lost his daughter Karunya, expressed disappointment in AstraZeneca’s delayed acknowledgment of the vaccine’s risks.
He called for justice for those who suffered complications after taking the vaccine.
COVID-19 Vaccine Safety Concerns
AstraZeneca is facing legal action over claims of serious injuries or fatalities linked to its vaccine.
The company acknowledged that its vaccine can rarely cause Thrombosis with Thrombocytopenia Syndrome (TTS).
Bharat Biotech and Covaxin
Bharat Biotech, the maker of Covaxin, emphasized the vaccine’s safety record amidst the AstraZeneca controversy.
Covaxin Safety Measures
Bharat Biotech highlighted its focus on safety during Covaxin’s development and efficacy trials.
The company stated that Covaxin underwent thorough safety evaluations and demonstrated an excellent safety record.
Government Approval and Safety
Covaxin was approved for use in the Indian government’s immunization program after extensive safety assessments.
Bharat Biotech assured the public that Covaxin had no reported cases of severe side effects like blood clots or related conditions.
